Relmada Therapeutics(RLMD) - 2025 Q1 - Earnings Call Transcript

Relmada Therapeutics (RLMD) Q1 2025 Earnings Call May 12, 2025 04:30 PM ET Company Participants Brian Ritchie - Managing DirectorSergio Traversa - CEO & Member of Board of DirectorsMaged Shenouda - Chief Financial OfficerUy Ear - Vice PresidentYair Lotan - Professor of Urology & Chief of Urologic OncologyMatthew Barcus - Senior Research Associate Operator Good afternoon. Welcome to Ramada Therapeutics First Quarter twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. A ...